secwatch.observer — SEC 8-K summary
======================================

Issuer:     Century Therapeutics, Inc. (IPSC)
CIK:        0001850119
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001104659-24-046373
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Century Therapeutics raises $60M and acquires Clade Therapeutics to expand autoimmune pipeline
--------------------------------------------------------------------------------

- Private placement of ~15.87M shares at $3.78 (April 10 close) led by Bain Capital Life Sciences; expected close April 15, 2024.
- Acquisition of Clade Therapeutics for ~$35M upfront ($15M cash + 4.535M shares) plus up to $10M milestone payment.
- Expanding CNTY-101 into additional autoimmune indications beyond SLE; CALiPSO-1 trial on track for H1 2024 initiation.
- Cash runway extended into 2026 with net proceeds from placement; pipeline adds three preclinical programs from Clade's ab iT platform.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850119/000110465924046373/0001104659-24-046373-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850119/000110465924046373/tm2411557d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-046373

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer